Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla-C Dubinsky

Showing results (161-170 of 247) with videos related to

Pageof 25
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 7, 2024
Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensusPablo A Olivera, Axel Dignass, Marla C Dubinsky, et al.
The American Journal of Gastroenterology|March 17, 2025
Symptom Resolution and Meaningful Improvement in Quality of Life With Risankizumab in Patients With Ulcerative Colitis: Post Hoc Analysis of the Randomized INSPIRE and COMMAND StudiesJoana Torres, Julian Panés, Corey A Siegel, et al.
Journal of Clinical Gastroenterology|June 11, 2021
Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBDEdward L Barnes, John S Hanson, Miguel D Regueiro, et al.
International Journal of Colorectal Disease|September 13, 2019
Emergent colectomy rates decreased while elective ileal pouch rates were stable over time: a nationwide inpatient sample studyMaia Kayal, Aparna Saha, Priti Poojary, et al.
Journal of Crohn'S & Colitis|July 4, 2023
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical ProgrammeStefan Schreiber, David T Rubin, Siew C Ng, et al.
The American Journal of Gastroenterology|August 13, 2021
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel DiseaseAdam S Cheifetz, Maria T Abreu, Waqqas Afif, et al.
Journal of Patient-Reported Outcomes|July 1, 2025
Bowel urgency in ulcerative colitis: effect of baseline urgency and change in urgency in response to mirikizumabDavid B Clemow, Marla C Dubinsky, Simin K Baygani, et al.
Frontiers in Immunology|March 13, 2024
Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-αElizabeth A Spencer, Marla C Dubinsky, Michael A Kamm, et al.
Frontiers in Immunology|March 13, 2024
Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-αElizabeth A Spencer, Marla C Dubinsky, Michael A Kamm, et al.
Inflammatory Bowel Diseases|November 5, 2025
Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's DiseaseMarla C Dubinsky, Geert D'Haens, Olivier Dewit, et al.
Pageof 25

Showing results (161-170 of 247) with videos related to

Sort By:
Pageof 25
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 7, 2024
Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensusPablo A Olivera, Axel Dignass, Marla C Dubinsky, et al.
The American Journal of Gastroenterology|March 17, 2025
Symptom Resolution and Meaningful Improvement in Quality of Life With Risankizumab in Patients With Ulcerative Colitis: Post Hoc Analysis of the Randomized INSPIRE and COMMAND StudiesJoana Torres, Julian Panés, Corey A Siegel, et al.
Journal of Clinical Gastroenterology|June 11, 2021
Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBDEdward L Barnes, John S Hanson, Miguel D Regueiro, et al.
International Journal of Colorectal Disease|September 13, 2019
Emergent colectomy rates decreased while elective ileal pouch rates were stable over time: a nationwide inpatient sample studyMaia Kayal, Aparna Saha, Priti Poojary, et al.
Journal of Crohn'S & Colitis|July 4, 2023
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical ProgrammeStefan Schreiber, David T Rubin, Siew C Ng, et al.
The American Journal of Gastroenterology|August 13, 2021
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel DiseaseAdam S Cheifetz, Maria T Abreu, Waqqas Afif, et al.
Journal of Patient-Reported Outcomes|July 1, 2025
Bowel urgency in ulcerative colitis: effect of baseline urgency and change in urgency in response to mirikizumabDavid B Clemow, Marla C Dubinsky, Simin K Baygani, et al.
Frontiers in Immunology|March 13, 2024
Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-αElizabeth A Spencer, Marla C Dubinsky, Michael A Kamm, et al.
Frontiers in Immunology|March 13, 2024
Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-αElizabeth A Spencer, Marla C Dubinsky, Michael A Kamm, et al.
Inflammatory Bowel Diseases|November 5, 2025
Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's DiseaseMarla C Dubinsky, Geert D'Haens, Olivier Dewit, et al.
Pageof 25